APA (7th ed.) Citation

Jyonouchi, H., Kornitzer, J., & Geng, L. Favorable responses to upadacitinib, a JAK1 inhibitor, in long COVID patients with predominant neuropsychiatric symptoms: Case reports in 2 autistic patients and one typically developing patient. BMC.

Chicago Style (17th ed.) Citation

Jyonouchi, Harumi, Jeffery Kornitzer, and Lee Geng. Favorable Responses to Upadacitinib, a JAK1 Inhibitor, in Long COVID Patients with Predominant Neuropsychiatric Symptoms: Case Reports in 2 Autistic Patients and One Typically Developing Patient. BMC.

MLA (9th ed.) Citation

Jyonouchi, Harumi, et al. Favorable Responses to Upadacitinib, a JAK1 Inhibitor, in Long COVID Patients with Predominant Neuropsychiatric Symptoms: Case Reports in 2 Autistic Patients and One Typically Developing Patient. BMC.